161 related articles for article (PubMed ID: 16115925)
1. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
Gulmann C; Espina V; Petricoin E; Longo DL; Santi M; Knutsen T; Raffeld M; Jaffe ES; Liotta LA; Feldman AL
Clin Cancer Res; 2005 Aug; 11(16):5847-55. PubMed ID: 16115925
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma: study of 116 cases.
Agarwal B; Naresh KN
Am J Hematol; 2002 Aug; 70(4):278-82. PubMed ID: 12210808
[TBL] [Abstract][Full Text] [Related]
3. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.
Zha H; Raffeld M; Charboneau L; Pittaluga S; Kwak LW; Petricoin E; Liotta LA; Jaffe ES
Lab Invest; 2004 Feb; 84(2):235-44. PubMed ID: 14767488
[TBL] [Abstract][Full Text] [Related]
4. [Complex diagnosis of follicular lymphomas].
Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
[TBL] [Abstract][Full Text] [Related]
5. Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20.
Cornfield DB; Mitchell DM; Almasri NM; Anderson JB; Ahrens KP; Dooley EO; Braylan RC
Am J Clin Pathol; 2000 Aug; 114(2):258-63. PubMed ID: 10941341
[TBL] [Abstract][Full Text] [Related]
6. BNIP3 expression in follicular lymphoma.
Sington J; Giatromanolaki A; Campo L; Turley H; Pezzella F; Gatter KC
Histopathology; 2007 Apr; 50(5):555-60. PubMed ID: 17394490
[TBL] [Abstract][Full Text] [Related]
7. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
Salakou S; Kardamakis D; Tsamandas AC; Zolota V; Apostolakis E; Tzelepi V; Papathanasopoulos P; Bonikos DS; Papapetropoulos T; Petsas T; Dougenis D
In Vivo; 2007; 21(1):123-32. PubMed ID: 17354625
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma.
Michels J; Foria V; Mead B; Jackson G; Mullee M; Johnson PW; Packham G
Br J Haematol; 2006 Mar; 132(6):743-6. PubMed ID: 16487175
[TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma.
Bilalovic N; Blystad AK; Golouh R; Nesland JM; Selak I; Trinh D; Torlakovic E
Am J Clin Pathol; 2004 Jan; 121(1):34-42. PubMed ID: 14750238
[TBL] [Abstract][Full Text] [Related]
11. Follicular lymphoma of the stomach: immunohistochemical and molecular genetic studies.
Kanda M; Ohshima K; Suzumiya J; Haraoka S; Kawasaki C; Sakisaka S; Kikuchi M
J Gastroenterol; 2003; 38(6):584-7. PubMed ID: 12856675
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of PU.1 in follicular lymphoma.
Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
[TBL] [Abstract][Full Text] [Related]
13. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells.
Bu X; Zheng Z; Wang C; Yu Y
Pathol Res Pract; 2007; 203(3):163-7. PubMed ID: 17307308
[TBL] [Abstract][Full Text] [Related]
14. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
[TBL] [Abstract][Full Text] [Related]
15. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
Olejniczak SH; Hernandez-Ilizaliturri FJ; Clements JL; Czuczman MS
Clin Cancer Res; 2008 Mar; 14(5):1550-60. PubMed ID: 18316580
[TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-2 family proteins in psoriasis.
Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
[TBL] [Abstract][Full Text] [Related]
17. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
[TBL] [Abstract][Full Text] [Related]
18. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
[TBL] [Abstract][Full Text] [Related]
20. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
